TCM
RETA

Tekla Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Tekla Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.49M Buy
2023
Q1 		$1.62M Buy
2021
Q3 		– Sell
2021
Q2 		$5.41M Hold
2021
Q1 		$3.81M Hold
2020
Q4 		$4.72M Sell
2020
Q3 		$7.45M Buy
2020
Q2 		$7.94M Buy
2020
Q1 		$5.07M Buy
2019
Q4 		$5.4M Buy